Introduction {#sec1}
============

Quinolinones are known to be one of the privileged structures in the recent drug discovery; in particular, 4-quinolinone derivatives exhibit unique and valuable biological properties such as antimalarial, antifungal, and antitumor activities.^[@ref1]^ As such, they are promising drug candidates; for instance, ciprofloxacin (Ciproxan) and levofloxacin (Cravit) are widely utilized as antibacterial drugs. Because of the importance of quinolinone scaffolds in recent drug developments, the expansion of the chemical space based on 4-quinolinone skeletons may assist in further discoveries of novel antibacterial drugs. In 2005, an unusual pyrrolyl 4-quinolinone alkaloid, quinolactacide (**1**), was isolated from *Penicillium citrinum* F 1539 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref2]^ Additionally, the related analogue penicinoline (**2**) was isolated from a mangrove endophytic fungus *Penicillium* sp.^[@ref3]^ The above-mentioned natural products possess unique structural features; for instance, they have an unusual pyrrole ring attached at the C-2 position and a carbonyl moiety at the C-3 position on the 4-quinolinone skeleton. In particular, **1** possesses a unique γ-lactam ring system that is produced by the lactamization of **2**. Quinolactacide (**1**) has been found to exhibit a potent insecticidal activity against the green peach aphid (*Myzus persicae*) at 250 parts per million (ppm), whereas penicinoline (**2**) has shown potent cytotoxicity against 95-D and HepG2 cell lines with IC~50~ values of 0.57 and 6.5 μg/mL, respectively. On the other hand, the decarboxylated derivative of **2** was not found to exhibit any biological properties, which suggests that the carbonyl moiety at the C-3 position is crucial for **2** to exhibit its biological activities.^[@ref4]^

![Structures of quinolactacide (**1**) and penicinoline (**2**).](ao-2017-00793h_0001){#fig1}

A synthetic method for developing 3-acyl- or 3-alkoxycarbonyl-4-quinolinone derivatives would be highly useful for the research and development of new antibacterial drugs. For example, several reactions, such as the Gould--Jacobs reaction,^[@ref5]^ the Grohe--Heitzer reaction,^[@ref6]^ and the palladium-catalyzed heterocycle formations,^[@ref7]^ are often used to synthesize quinolinone derivatives; however, harsh conditions are required to prepare 4-quinolinones. Recently, we have reported a concise and regioselective synthesis of 3-acylflavones through a Lewis base catalyzed tandem acyl transfer--cyclization of *o*-alkynoylphenol derivatives, and this method successfully provides a chromone skeleton comprising an aryl group at the C-2 position and an acyl moiety at the C-3 position ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).^[@ref8]^ As 4-quinolinone skeletons possess a ring system similar to those of flavone derivatives, we assumed that specific 3-acyl-4-quinolinone skeletons can be readily prepared under ambient conditions from *o*-alkynoylaniline derivatives using Lewis base catalyzed reactions similar to the synthesis of 3-acylflavones. Herein, we report on the facile synthesis of quinolactacide (**1**) and its analogues via 9-azajulolidine (9-AJ)-catalyzed tandem acyl transfer--cyclization of *N*,*N*-diacyl-*o*-alkynoylanilines.

![Synthetic plan for 3-acyl-4-quinolinone derivatives.](ao-2017-00793h_0002){#fig2}

The retrosynthesis of quinolactacide (**1**) and its analogues is illustrated in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. Quinolactacide (**1**) can be obtained from a common intermediate methyl penicinoline (**3**) through lactamization under basic conditions. The key intermediate **3** can be readily prepared in one pot via the Lewis base catalyzed tandem acyl transfer--cyclization of *o*-alkynoylaniline derivative **4** that is protected by *tert*-butoxycarbonyl and methoxycarbonyl groups. To synthesize the key intermediate **4** in a chemo- and regioselective manner, the methoxycarbonyl group on **4** should be selectively transferred to the C-3 position on the 4-quinolinone skeleton rather than the bulky *tert*-butoxycarbonyl group. In 2006, the synthesis of quinolactacide (**1**) was reported by Abe et al., wherein they successfully synthesized **1** from [l]{.smallcaps}-proline by utilizing the MnO~2~-mediated dehydrative aromatization of the pyrrolidine ring.^[@ref9]^ However, harsh oxidative conditions are required to construct the pyrrole ring at the later stage of this synthesis; this meant that the introduction of functional groups on the pyrrole ring would be limited. We assume that our convergent approach would be effective for synthesizing various analogues of quinolactacide (**1**).

![Retrosynthesis of Quinolactacide (**1**)](ao-2017-00793h_0007){#sch1}

Results and Discussion {#sec2}
======================

To begin with, we investigated the reaction conditions for the synthesis of the 3-acyl-4-quinolinone skeleton using *N*-Boc-*N*-benzoylalkynoylaniline **5a** as the substrate. Substrates **5** were prepared from *N*-Boc-2-iodoaniline (**6**)^[@ref10]^ using *N*-acylation and carbonylative Sonogashira coupling with phenylacetylene, as shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. The reaction of **5a** proceeded in the presence of 30 mol % 4-(dimethylamino)pyridine (DMAP) to provide 3-benzoyl-4-quinolinone **8a** in 66% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). The structure of **8a** was unambiguously confirmed using X-ray crystallographic analysis (X-ray crystal structure deposition number: CCDC 1542139), which indicated that a smaller benzoyl group was selectively transferred to the C-3 position on the quinolinone skeleton under the reaction conditions ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). To improve the yield of **8a**, we conducted further investigations with a number of Lewis base catalysts: 4-Pyrrolidinopyridine (PPY)^[@ref11]^ was found to be ineffective for inducing either an acyl transfer or a 6-endo cyclization (55% yield, entry 2). Interestingly, 9-AJ^[@ref12]^ efficiently promoted the reaction leading to **8a** in 84% yield (entry 3). On the other hand, a decrease in the yield of **8a** was observed on either performing the reaction at 50 °C or reducing the amount of 9-AJ (entries 4 and 5). In addition, the reaction in a less polar or nonpolar solvent gave poor results; the use of MeCN as a solvent significantly decreased the yield of **8a** (50%, entry 6); and substrate **7a** was not completely consumed in 48 h, when the reaction was performed in tetrahydrofuran (THF) or toluene (entries 7 and 8). It is noteworthy that the use of dimethylformamide (DMF) as a solvent is crucial to provide **8a** in the desirable yield. We also investigated the Lewis bases for the reaction; however, sufficient amounts of **8a** were not produced in the presence of other Lewis bases such as 1,4-diazabicyclo\[2.2.2\]octane (DABCO), PPh~3~, PCy~3~, and PBu~3~ (entries 9--12); substrate **5a**, in particular, was completely recovered due to the low nucleophilicity of DABCO and PPh~3~ to the substrate under these conditions. In contrast to DABCO and PPh~3~, trialkylphosphines, such as PCy~3~ and PBu~3~, showed enough nucleophilicity to promote the reaction at ambient temperature; however, it was observed that hardly any quinolinone **8a** was obtained, and instead, 5-exo-cyclized indolinone **10** was isolated in 5% yield from the resulting mixture (entry 12). We assumed that a less-hindered amide bond might be cleaved by the nucleophilic PBu~3~ to provide anilide **9**, which would subsequently be converted to the corresponding indolinone derivative **10** by 5-exo cyclization,^[@ref13]^ as shown in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}.^[@ref14]^

![Oak Ridge thermal ellipsoid plot (ORTEP) drawing of the X-ray crystal structure of **8a**.](ao-2017-00793h_0003){#fig3}

![Preparation of Substrates **5** from *N*-Boc-2-iodoaniline (**6**)](ao-2017-00793h_0008){#sch2}

![Plausible Mechanism of the Formation of Indolinone Derivative **10**](ao-2017-00793h_0009){#sch3}

###### Investigation of the Reaction Conditions for the Tandem Acyl Transfer--Cyclization

![](ao-2017-00793h_0013){#GRAPHIC-d85e523-autogenerated}

  entry[a](#t1fn1){ref-type="table-fn"}    catalyst (mol %)   solvent   Temp (°C)   time (h)   yield of **8a**[b](#t1fn2){ref-type="table-fn"} (%)   recovery of **5a**[b](#t1fn2){ref-type="table-fn"} (%)
  --------------------------------------- ------------------ --------- ----------- ---------- ----------------------------------------------------- --------------------------------------------------------
  1                                           DMAP (30)         DMF        30          48                              66                                                      13
  2                                            PPY (30)         DMF        30          48                              55                                                      29
  3                                           9-AJ (30)         DMF        30          19                              84                                                      0
  4                                           9-AJ (30)         DMF        50          8                               60                                                      0
  5                                           9-AJ (10)         DMF        30          48                              77                                                      0
  6                                           9-AJ (30)        MeCN        30          19                              50                                                      0
  7                                           9-AJ (30)       toluene      30          48                              33                                                      23
  8                                           9-AJ (30)         THF        30          48                              30                                                      7
  9                                           DABCO (30)        DMF        30          48                               0                                                      91
  10                                         PPh~3~ (30)        DMF        30          48                               0                                                      84
  11                                         PCy~3~ (30)        DMF        30          48                               0                                                      32
  12                                         PBu~3~ (30)        DMF        30          48               0[c](#t1fn3){ref-type="table-fn"}                                      0

The reaction was performed in 0.1 mmol scale of **5a**.

Isolated yield.

**10** was isolated (5%).

Following the above-mentioned process, we investigated the scope of the substrate in the 9-AJ-catalyzed reaction. The results are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The reactions of substrate **5b** possessing a methoxycarbonyl group and **5c** having an ethoxycarbonyl group were completed in 21 h at ambient temperature to afford the desired **8b** and **8c** in moderate-to-excellent yields (entries 1 and 2). However, the bulkiness of the R group significantly diminished the yield of the corresponding 4-quinolinone derivatives; the tandem acyl transfer--cyclization of **5d** (R = isopropoxy) slowly proceeded, leading to the corresponding **8d** in 44% yield (entry 3). Notably, the reaction of substrate **5e**, which comprised bis(*tert*-butoxycarbonyl) groups, led to a complex mixture when the reaction was conducted at 80 °C (entry 4). In contrast to substrate **5a** consisting of a phenyl group as the R moiety, the reaction of **5f** was completed within 3 h because the electrophilicity of the acyl group increased due to the electron-withdrawing para-chloride atom on the phenyl ring, and the corresponding **8f** was afforded in 84% yield (entry 5). On the other hand, substrate **5g** was slowly consumed because of an electron-donating para-methoxy group leading to **8g** in 81% yield (entry 6). In addition, the reaction of **5i** with a meta-methoxy group was complete in 13 h to afford **8i** in 79% yield (entry 8), whereas substrate **5h** possessing a meta-chloride atom was smoothly converted into the corresponding **8h** (entry 7). The above-mentioned observation indicated that a para-substituent on the phenyl ring affected the reactivity in the rearrangement of the acyl group to the C-3 position, which was consistent with the results previously reported for the synthesis of 3-acylflavones.^[@ref8]^ Next, we investigated the reaction of alkanamide derivatives. Low yields of 3-acyl-4-quinolinones **8j** and **8k** were observed when the substrates possessing an acetyl and a 2-methylpropanoyl group were used (entries 9 and 10). On the other hand, substrate **5l** possessing a pivaloyl group was successfully converted to the corresponding **8l** in a moderate yield (entry 11), indicating that the presence of an acidic α-proton in the acyl moiety, such as in the acetyl and 2-methylpropanoyl groups, would be problematic to give the desired 3-acyl-4-quinolinones in the acceptable yield. In addition, substrate **11** possessing a methyl group instead of the Boc group on the nitrogen was also subjected to the reaction conditions mentioned above; however, the reaction did not proceed at all to provide product **12** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). This is likely because the *N*-alkylamide bond was less cleavable than the electron-deficient *N*-Boc amide because of an electron-donating alkyl group, which indicated that an *N*,*N*-diacyl moiety is necessary to induce the acyl transfer leading to the desired 3-acyl-4-quinolinone skeleton.

![Attempt for the Acyl Transfer--Cyclization of **11**](ao-2017-00793h_0010){#sch4}

###### Scope and Limitation of the 9-AJ-Catalyzed Tandem Acyl Transfer--Cyclization of **5**

![](ao-2017-00793h_0014){#GRAPHIC-d85e991-autogenerated}

  entry[a](#t2fn1){ref-type="table-fn"}              R             time (h)   yield of **8** (%)[b](#t2fn2){ref-type="table-fn"}
  --------------------------------------- ----------------------- ---------- ----------------------------------------------------
  1                                             **5b**: OMe           21                          **8b**: 93
  2                                             **5c**: OEt           21                          **8c**: 75
  3                                          **5d**: O^*i*^Pr         31                          **8d**: 44
  4[c](#t2fn3){ref-type="table-fn"}          **5e**: O^*t*^Bu        120                          **8e**: 0
  5                                        **5f**: 4-ClC~6~H~4~       3                           **8f**: 84
  6                                        **5g**: 4-MeOC~6~H~4~      27                          **8g**: 81
  7                                        **5h**: 3-ClC~6~H~4~       5                           **8h**: 87
  8                                        **5i**: 3-MeOC~6~H~4~      13                          **8i**: 79
  9                                             **5j**: Me            48                          **8j**: 25
  10                                          **5k**: ^*i*^Pr         48                          **8k**: 35
  11                                          **5l**: ^*t*^Bu         44                          **8l**: 56

The reaction was performed in 0.1 mmol scale of **5**.

Isolated yield.

The reaction was performed at 80 °C.

We next attempted to isolate a reaction intermediate using substrate **5m** containing bis-Boc groups on the nitrogen atom to elucidate the reaction mechanism ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). No intermediate was observed by the thin-layer chromatography (TLC) analysis in the presence of a slightly excess amount of 9-AJ; however, the addition of 1 equiv of Brønsted acid smoothly converted substrate **5m** to an *E*/*Z* mixture of 9-AJ adducts. The *E*-isomer of 9-AJ adduct **13m** was partially separated by high-performance liquid chromatography (HPLC), and the structural assignment of the *E*-isomer was conducted by nuclear Overhauser enhancement spectroscopy (NOESY), as shown in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}. In addition, the time course of the 9-AJ-catalyzed reaction of substrate **5b** was monitored using proton nuclear magnetic resonance (^1^H NMR) spectroscopy in DMF-*d*~7~ at 30 °C ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Substrate **5b** was found to be gradually consumed, and the substrate was completely converted to the corresponding quinolinone **8b** in 21 h. Interestingly, a presumable intermediate, such as allenolate **14b** or enone **15b**, was not observed, and the chemical shifts of 9-AJ did not change during the time course experiment in DMF-*d*~7~; this indicates that an acyl transfer to the C-3 position and the 6-endo cyclization of the resulting enone **15b** would subsequently occur at ambient temperature after the formation of allenolate **14b**.

![^1^H NMR monitoring of the 9-AJ-catalyzed reaction of **5b** in DMF-*d*~7~. (A) ^1^H NMR spectrum of substrate **5b**; (B) ^1^H NMR spectrum of 9-AJ; (C) ^1^H NMR spectrum of the reaction mixture in 1 h; (D) ^1^H NMR spectrum of the reaction mixture in 8 h; (E) ^1^H NMR spectrum of the reaction mixture in 21 h; and (F) ^1^H NMR spectrum of product **8b**.](ao-2017-00793h_0004){#fig4}

![Attempt for the Isolation of 9-AJ Adduct **13m**](ao-2017-00793h_0011){#sch5}

We also noticed that the addition of Brønsted acid induced 1,4-addition of 9-AJ to the ynone system, indicating that the activation of the carbonyl moiety in the ynone system would be crucial to promote this reaction. In addition, we assumed that an acyl group on the nitrogen atom could act as an activator of the carbonyl moiety in the ynone system, as shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. In fact, the reaction of **5f** possessing an electron-withdrawing acyl group quickly afforded **8f** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 5), whereas substrate **5g** was slowly converted into **8g** (entry 6). This can be because the increase in the electrophilicity of the acyl group may prove conducive for the activation of the carbonyl moiety in the ynone system, leading to intermediate **16**, which shows that 1,4-addition of 9-AJ was smoothly induced to promote the following reactions such as the acyl transfer to the C-3 position and 6-endo cyclization.

![Plausible activation of the carbonyl moiety in the ynone system.](ao-2017-00793h_0005){#fig5}

On the basis of the extensive consideration of the reaction mechanism, the plausible mechanism of the 9-AJ-catalyzed reaction can be explained as follows: 1,4-addition of 9-AJ to substrate **5** occurs and the nucleophilic attack of the resulting anion to the less-hindered acyl group would subsequently occur to provide intermediate **16**, which can reversibly be converted into two potential structures: anilide **17** (path a) and allenolate **14** (path b). As the anilide moiety in **17** does not undergo 5-exo cyclization when using 9-AJ as the catalyst, **17** would transform allenolate **14** through intermediate **16**. The less-hindered acyl group in **14** can then be irreversibly transferred to the C-3 position, leading to enone **15**. The resulting enone **15** is a good Michael acceptor; therefore, 6-endo cyclization readily occurs, and the following elimination of 9-AJ exclusively provides 3-acyl-4-quinolinone derivative **8** ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). Because no intermediate was observed in the time course NMR experiment, as illustrated in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, we assumed that the 1,4-addition of 9-AJ to substrate **5** was the rate-determining step in this quinolinone synthesis.

![Plausible reaction mechanism for the 9-AJ-catalyzed tandem acyl transfer--cyclization of *o*-alkynoylaniline **5** leading to 3-acyl-4-quinolinone **8**.](ao-2017-00793h_0006){#fig6}

We then applied this method to the total synthesis of quinolactacide (**1**) and its analogues using the 9-AJ-catalyzed reaction, and the details of the synthesis are illustrated in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}. Sonogashira coupling of *N*-Boc-2-bromopyrrole (**18**)^[@ref15]^ with trimethylsilyl (TMS) acetylene, followed by the removal of the TMS group, provided alkyne **19** in 88% yield. The resulting derivative **19** was then subjected to Pd(0)-catalyzed carbonylative Sonogashira coupling with iodoaniline derivative **7b** in the presence of CuI under 50 atm of carbon monoxide at 80 °C to afford the desired *o*-alkynoylaniline derivative **4** in 64% yield. 9-AJ (30 mol %) was found to efficiently promote the tandem acyl transfer--cyclization of **4** at 80 °C, whereas the reaction did not proceed at room temperature because of an electron-rich pyrrole group. We also observed the partial removal of the Boc group during the formation of the 3-acyl-4-quinolinone skeleton; therefore, the remaining Boc group was subsequently removed under acidic conditions, which led to the production of methyl penicinoline (**3**)^[@ref16]^ in 54% yield. As a final step, the lactamization of **3** utilizing 1,8-diazabicyclo\[5.4.0\]undec-7-ene (DBU) furnished quinolactacide (**1**), which underwent N-methylation, leading to penicinotam (**20**) in 95% yield ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The spectral data for the synthetic quinolactacide (**1**) and the related analogues were in good agreement with those of the natural products and the synthetic compound.^[@ref1],[@ref2]^

![Synthesis of Quinolactacide (**1**) and Penicinotam (**20**)](ao-2017-00793h_0012){#sch6}

In conclusion, we have demonstrated a concise synthesis of 3-acyl-4-quinolinones via the Lewis base catalyzed tandem acyl transfer--cyclization of *N*,*N*-diacyl-*o*-alkynoylanilines **5** and have applied it to the synthesis of unusual pyrrolyl 4-quinolinone alkaloids. 9-AJ (30 mol %) was found to efficiently promote the reaction at ambient temperature, and the corresponding 3-acyl-4-quinolinones **8** were produced in moderate-to-good yields. Notably, a less-hindered acyl group on the nitrogen atom was selectively transferred to the C-3 position on the quinolinone skeleton. A time course experiment of substrate **5b** using ^1^H NMR was conducted, and we found that no intermediate was observed during this experiment. On the other hand, 9-AJ adduct **13m** was successfully obtained by treatment with an excess amount of 9-AJ, followed by the addition of 1 equiv of Brønsted acid. Therefore, we speculated that 1,4-addition of 9-AJ to the ynone system is the rate-determining step for this reaction. In addition, this method was applied to the synthesis of pyrrolyl 4-quinolinone alkaloid quinolactacide (**1**) and related analogues. *o*-Alkynoylaniline derivative **4** was readily consumed in the presence of 30 mol % 9-AJ at 80 °C, and the subsequent removal of the Boc group under acidic conditions afforded methyl penicinoline (**3**) in 54% yield. The syntheses of quinolactacide (**1**) and penicinotam (**20**) were readily achieved from intermediate **3** by lactamization and N-methylation under basic conditions. Notably, the Lewis base catalyzed tandem acyl transfer--cyclization we developed can be applied to the synthesis of functionalized benzoheterocycles. We will report on the synthesis of benzocarbocycle natural products using this methodology in due course.

Experimental Section {#sec3}
====================

General Techniques {#sec3-1}
------------------

Chemicals and solvents were all purchased from commercial supplies and used without further purification. All reactions in the solution phase were monitored by TLC carried out on glass-packed silica gel plates (60F-254) with UV light and visualized by *p*-anisaldehyde H~2~SO~4~ ethanol solution or phosphomolybdic acid ethanol solution. Flash column chromatography was carried out with silica gel (40--100 μm) with the indicated solvent system. ^1^H NMR spectra (400 and 600 MHz) and ^13^C NMR spectra (100 and 150 MHz) were recorded in the indicated solvent. Chemical shifts (δ) are reported in unit ppm relative to the signal for internal tetramethylsilane (0.00 ppm for ^1^H) for solutions in CDCl~3~. NMR spectral data are reported as follows: chloroform (7.26 ppm for ^1^H) or chloroform-*d* (77.0 ppm for ^13^C), methanol (3.30 ppm for ^1^H) or methanol-*d*~4~ (49.0 ppm for ^13^C), and dimethyl sulfoxide (2.49 ppm for ^1^H) or dimethyl sulfoxide-*d*~6~ (39.5 ppm for ^13^C) when internal standard is not indicated. Multiplicities are reported by the following abbreviations: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (double doublet), dt (double triplet), ddd (double double doublet), ddt (double double triplet), dddd (double double double doublet), br s (broad singlet), br d (broad doublet), and *J* (coupling constants in hertz). High-resolution mass spectra were measured on a time-of-flight mass spectrometer (TOF-MS) with an electrospray ionization (ESI) or fast atom bombardment (FAB) probe. Infrared spectra are reported in reciprocal centimeters (cm^--1^). Melting points were measured on a melting point apparatus and are not corrected. HPLC analysis was performed on an HPLC system with a photodiode array detector and an analytical C~18~ column (3.5 μm, 4.6 × 75 mm i.d.) at a flow rate of 1.1 mL/min with a gradient solvent (0 min, 10% MeOH/H~2~O; 4 min, 95% MeOH/H~2~O; 11 min, 95% MeOH/H~2~O; 11.1 min, 10% MeOH/H~2~O; and 15 min, 10% MeOH/H~2~O). HPLC solvents (MeOH and H~2~O) were buffered with 0.1% liquid chromatography--mass spectrometry (LC--MS) grade formic acid.

### General Procedure for the Synthesis of *N*-Boc-*N*-acyl-2-iodoaniline 7 from *N*-Boc-2-iodoaniline (**6**) {#sec3-1-1}

To a solution of *N*-Boc-2-iodoaniline (**6**) (3.0 mmol, 1.00 equiv) in dry THF (9 mL, 3.00 mL/mmol) was added sodium hydride (4.5 mmol, 1.50 equiv) at 0 °C under argon. After being stirred at the same temperature for 10 min, acyl chloride (3.6 mmol, 1.20 equiv) was added at −78 °C. After being stirred at the same temperature for 1 h, the reaction mixture was quenched with 1 M aqueous HCl at 0 °C. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NaHCO~3~ and brine, dried over MgSO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel (eluted with hexane/ethyl acetate = 20/1 to 10/1) to afford *N*-Boc-*N*-acyl-2-iodoaniline **7**.

#### *N*-Boc-*N*-benzoyl-2-iodoaniline (**7a**) {#sec3-1-1-1}

Yield: 97% (1.23 g, 2.91 mmol), white solid, mp 113--115 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.93 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.81 (m, 2H), 7.52 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.46--7.40 (m, 3H), 7.30 (dd, 1H, *J* = 8.0, 1.2 Hz), 7.08 (ddd, 1H, *J* = 8.0, 8.0, 1.2 Hz), 1.25 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 171.4, 152.0, 141.7, 139.8, 136.7, 131.4, 129.8, 129.7, 129.2, 128.3, 128.0, 99.4, 83.8, 27.5; FT-IR (neat): 1739, 1686, 1346, 1238, 1151 cm^--1^; HRMS \[ESI\]: calcd for C~18~H~18~INO~3~Na \[M + Na\]^+^ 446.0229; found 446.0213.

#### *N*-Boc-*N*-methoxycarbonyl-2-iodoaniline (**7b**) {#sec3-1-1-2}

Yield: 78% (883 mg, 2.34 mmol), white solid, mp 91--93 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.87 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.38 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.23 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.05 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 3.77 (s, 3H, f), 1.41 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 152.4, 149.9, 141.3, 139.1, 129.3, 129.0, 128.9, 99.5, 83.3, 53.8, 27.7; FT-IR (neat): 1797, 1760, 1731, 1279, 1157, 1103 cm^--1^; HRMS \[ESI\]: calcd for C~13~H~16~INO~4~Na \[M + Na\]^+^ 400.0022; found 400.0005.

#### *N*-Boc-*N*-ethoxycarbonyl-2-iodoaniline (**7c**) {#sec3-1-1-3}

Yield: quant (1.17 g, 3.00 mmol), white solid, mp 67--69 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.86 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.37 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.23 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.04 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 4.22 (m, 2H), 1.42 (s, 9H), 1.23 (t, 3H, *J* = 7.0 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 151.8, 150.0, 141.4, 139.1, 129.2, 129.0, 128.9, 99.5, 83.1, 62.9, 27.7, 14.1; FT-IR (neat): 1796, 1758, 1729, 1369, 1278, 1158, 1097 cm^--1^; HRMS \[ESI\]: calcd for C~14~H~18~INO~4~Na \[M + Na\]^+^ 414.0178; found 414.0155.

#### *N*-Boc-*N*-isopropoxycarbonyl-2-iodoaniline (**7d**) {#sec3-1-1-4}

Yield: 82% (997 mg, 2.46 mmol), colorless crystal, mp 87--89 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.85 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.36 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.22 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.03 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 5.02 (sept, 1H, *J* = 6.4 Hz), 1.42 (s, 9H), 1.22 (d, 3H, *J* = 6.4 Hz), 1.17 (d, 3H, *J* = 6.4 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 151.4, 150.2, 141.6, 139.1, 129.2, 129.0, 128.9, 99.7, 83.1, 70.8, 27.8, 21.6; FT-IR (neat): 2981, 1795, 1756, 1727, 1369, 1267, 1160, 1099 cm^--1^; HRMS \[ESI\]: calcd for C~15~H~20~INO~4~Na \[M + Na\]^+^ 428.0335; found 428.0315.

#### *N*,*N*-Di-Boc-2-iodoaniline (**7e**) {#sec3-1-1-5}

Yield: 96% (1.21 g, 2.88 mmol), white solid, mp 109--111 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.84 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.34 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.20 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.00 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 1.40 (s, 18H); ^13^C NMR (100 MHz, CDCl~3~) δ: 150.3, 142.0, 139.0, 128.9, 128.8, 99.7, 82.8, 27.8; FT-IR (neat): 1754, 1726, 1369, 1281, 1243, 1152, 1117 cm^--1^; HRMS \[EI\]: calcd for C~16~H~22~INO~4~Na 442.0491; found 442.0470.

#### *N*-Boc-*N*-(4-chlorobenzoyl)-2-iodoaniline (**7f**) {#sec3-1-1-6}

Yield: 98% (1.35 g, 2.94 mmol), colorless oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.92 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.76 (d, 2H, *J* = 8.4 Hz), 7.42 (m, 3H), 7.28 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.09 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 1.29 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 170.3, 151.9, 141.3, 139.7, 137.7, 134.9, 129.9, 129.8, 129.3, 128.3, 99.3, 84.1, 27.5; FT-IR (neat): 1741, 1688, 1346, 1276, 1250, 1152 cm^--1^; HRMS \[ESI\]: calcd for C~18~H~17~ClINO~3~Na \[M + Na\]^+^ 479.9834; found 479.9822.

#### *N*-Boc-*N*-(4-methoxybenzoyl)-2-iodoaniline (**7g**) {#sec3-1-1-7}

Yield: quant (1.36 g, 3.00 mmol), colorless oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.91 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.82 (d, 2H, *J* = 8.8 Hz), 7.40 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.28 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.06 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 6.94 (d, 2H, *J* = 8.8 Hz), 3.86 (s, 3H), 1.30 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 170.6, 162.5, 152.3, 142.0, 139.7, 130.9, 129.9, 129.5, 129.1, 128.4, 113.2, 99.5, 83.4, 55.4, 27.6; FT-IR (neat): 1735, 1684, 1604, 1345, 1254, 1150 cm^--1^; HRMS \[ESI\]: calcd for C~19~H~20~INO~4~Na \[M + Na\]^+^ 476.0329; found 476.0314.

#### *N*-Boc-*N*-(3-chlorobenzoyl)-2-iodoaniline (**7h**) {#sec3-1-1-8}

Yield: 99% (1.36 g, 2.97 mmol), white solid, mp 100--101 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.93 (dd, 1H, *J* = 8.0, 1.2 Hz), 7.78 (dd, 1H, *J* = 1.6, 1.6 Hz), 7.68 (ddd, 1H, *J* = 1.2, 1.2, 7.6 Hz), 7.50 (ddd, 1H, *J* = 1.2, 1.2, 8.0 Hz), 7.44 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.39 (dd, 1H, *J* = 8.0, 8.0 Hz), 7.30 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.10 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 1.28 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 169.9, 151.7, 141.2, 139.8, 138.3, 134.0, 131.3, 129.9, 129.7, 129.4, 129.3, 128.3, 126.3, 99.3, 84.2, 27.5; FT-IR (neat): 2938, 1725, 1679, 1467, 1348, 1234, 1148, 731 cm^--1^; HRMS \[ESI\]: calcd for C~18~H~17~ClINO~3~Na \[M + Na\]^+^ 479.9834; found 479.9828.

#### *N*-Boc-*N*-(3-methoxybenzoyl)-2-iodoaniline (**7i**) {#sec3-1-1-9}

Yield: 86% (1.17 g, 2.58 mmol), white solid, mp 104--106 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.93 (dd, 1H, *J* = 8.0, 1.2 Hz), 7.36 (m, 5H), 7.08 (m, 2H), 3.84 (s, 3H), 1.27 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 171.0, 159.2, 151.9, 141.5, 139.7, 137.7, 129.7, 129.6, 129.1, 128.9, 120.5, 117.5, 113.2, 99.3, 83.6, 55.34, 55.32, 27.4; FT-IR (neat): 2934, 1735, 1676, 1580, 1348, 1257, 1156, 751 cm^--1^; HRMS \[ESI\]: calcd for C~19~H~20~INO~3~Na \[M + Na\]^+^ 476.0329; found 476.0322.

#### *N*-Boc-*N*-acetyl-2-iodoaniline (**7j**) {#sec3-1-1-10}

Yield: 70% (758 mg, 2.1 mmol), white solid, mp 101--103 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.86 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.38 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.15 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.04 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 2.63 (s, 3H), 1.39 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 172.2, 151.5, 141.7, 139.3, 129.4, 129.2, 129.1, 99.5, 83.4, 27.8, 26.6; FT-IR (neat): 1737, 1709, 1277, 1255, 1154, 1104 cm^--1^; HRMS \[ESI\]: calcd for C~13~H~16~INO~3~Na \[M + Na\]^+^ 384.0073; found 384.0057.

#### *N*-Boc-*N*-isobutyryl-2-iodoaniline (**7k**) {#sec3-1-1-11}

Yield: quant (1.17 g, 3.00 mmol), white solid, mp 59--61 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.86 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.37 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.13 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.02 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 3.77 (sept, 1H, *J* = 6.4 Hz), 1.39 (s, 9H), 1.30 (d, 3H, *J* = 6.4 Hz), 1.24 (d, 3H, *J* = 6.4 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 179.2, 151.1, 141.9, 139.1, 129.08, 129.06, 128.9, 99.4, 83.0, 34.6, 27.7, 19.6, 19.4; FT-IR (neat): 1740, 1708, 1271, 1249, 1153, 1101, 1080 cm^--1^; HRMS \[ESI\]: calcd for C~15~H~20~INO~3~Na \[M + Na\]^+^ 412.0386; found 412.0367.

#### *N*-Boc-*N*-pivaloyl-2-iodoaniline (**7l**) {#sec3-1-1-12}

Yield: 84% (1.02 g, 2.52 mmol), colorless crystal, mp 80--82 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 7.87 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.35 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.13 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.01 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 1.41 (s, 9H), 1.40 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 182.6, 152.3, 142.9, 139.7, 129.1, 129.0, 128.9, 99.8, 82.8, 43.4, 28.0, 27.8; FT-IR (neat): 1735, 1697, 1297, 1273, 1254, 1152, 1082 cm^--1^; HRMS \[ESI\]: calcd for C~16~H~22~INO~3~Na \[M + Na\]^+^ 426.0542; found 426.0526.

### General Procedure for the Synthesis of *o*-Alkynoylaniline Derivatives 5 from *N*,*N*-Diacyl-2-iodoaniline **7** {#sec3-1-2}

In a 50 mL autoclave containing a glass tube were placed *N*,*N*-diacyl-2-iodoaniline **7** (1.00 mmol, 1.00 equiv), phenylacetylene derivative (1.2 mmol, 1.20 equiv), triethylamine (3.00 mmol 3.00 equiv), DMF (6.0 mL, 6.00 mL/mmol), Pd(PPh~3~)~4~ (0.01 mmol, 0.0100 equiv), and CuI (0.02 mmol, 0.0200 equiv). The autoclave was filled with carbon monoxide (50 atm) after being purged with carbon monoxide three times. The reaction was carried out under an appropriate carbon monoxide pressure at 80 °C for 12 h. The reaction mixture was diluted with water. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NH~4~Cl and brine, dried over MgSO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel (eluted with hexane/ethyl acetate = 15/1 to 7/1) to afford *o*-alkynoylaniline derivative **5**.

#### *N*-Benzoyl-*N*-Boc-2-(3-phenylprop-2-ynoyl)aniline (**5a**) {#sec3-1-2-1}

Yield: 72% (306 mg, 0.72 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.40 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.79 (dd, 2H, *J* = 8.0, 1.2 Hz), 7.66 (m, 3H), 7.56 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.52--7.38 (m, 6H), 7.34 (dd, 1H, *J* = 8.0, 1.6 Hz), 1.21 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.9, 172.2, 152.4, 138.3, 137.1, 134.03, 133.95, 133.3, 133.1, 131.1, 130.8, 128.6, 128.4, 128.1, 127.9, 120.0, 92.7, 87.7, 83.6, 27.4; FT-IR (neat): 2197, 1736, 1681, 1644, 1352, 1269, 1240, 1152 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~23~NO~4~Na \[M + Na\]^+^ 448.1525; found 448.1511.

#### *N*-Boc-*N*-methoxycarbonyl-2-(3-phenylprop-2-ynoyl)aniline (**5b**) {#sec3-1-2-2}

Yield: 70% (266 mg, 0.70 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.28 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.72 (dd, 2H, *J* = 7.8, 1.6 Hz), 7.63 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.54--7.46 (m, 2H), 7.42 (dd, 2H, *J* = 7.8, 7.8 Hz), 7.24 (dd, 1H, *J* = 8.0, 1.6 Hz), 3.72 (s, 3H), 1.36 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.1, 153.0, 150.5, 138.3, 133.9, 133.6, 133.4, 131.9, 130.8, 130.0, 128.5, 128.3, 119.9, 93.1, 87.8, 83.3, 53.7, 27.6; FT-IR (neat): 2195, 1797, 1761, 1727, 1644, 1278, 1158, 1103 cm^--1^; HRMS \[ESI\]: calcd for C~22~H~21~NO~5~Na \[M + Na\]^+^ 402.1317; found 402.1301.

#### *N*-Boc-*N*-ethoxycarbonyl-2-(3-phenylprop-2-ynoyl)aniline (**5c**) {#sec3-1-2-3}

Yield: 46% (181 mg, 0.46 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.27 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.73 (dd, 2H, *J* = 7.8, 1.6 Hz), 7.62 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.53--7.45 (m, 2H), 7.41 (dd, 2H, *J* = 7.8, 7.8 Hz), 7.24 (dd, 1H, *J* = 8.0, 1.2 Hz), 4.18 (q, 1H, *J* = 7.2 Hz), 1.36 (s, 9H), 1.16 (t, 3H, *J* = 7.2 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.0, 152.4, 150.5, 138.5, 133.8, 133.6, 133.4, 131.7, 130.7, 130.0, 128.5, 128.2, 119.8, 93.0, 87.9, 83.2, 62.8, 27.6, 14.0; FT-IR (neat): 2195, 1795, 1758, 1273, 1158, 1097 cm^--1^; HRMS \[ESI\]: calcd for C~23~H~23~NO~5~Na \[M + Na\]^+^ 416.1474; found 416.1459.

#### *N*-Boc-*N*-isopropoxycarbonyl-2-(3-phenylprop-2-ynoyl)aniline (**5d**) {#sec3-1-2-4}

Yield: 47% (192 mg, 0.47 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.26 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.74 (dd, 2H, *J* = 7.8, 1.6 Hz), 7.61 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.51--7.45 (m, 2H), 7.41 (dd, 2H, *J* = 7.8, 7.8 Hz), 7.23 (d, 1H, *J* = 8.0 Hz), 4.98 (sept, 1H, *J* = 6.0 Hz), 1.36 (s, 9H), 1.13 (d, 6H, *J* = 6.0 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.0, 151.9, 150.7, 138.7, 133.7, 133.6, 133.4, 131.6, 130.7, 130.0, 128.5, 128.1, 119.9, 93.0, 87.9, 83.1, 70.8, 27.7, 21.5; FT-IR (neat): 2196, 1794, 1756, 1308, 1270, 1160, 1099 cm^--1^; HRMS \[ESI\]: calcd for C~24~H~25~NO~5~Na \[M + Na\]^+^ 430.1630; found 430.1614.

#### *N*,*N*-Di-Boc 2-(3-phenylprop-2-ynoyl)aniline (**5e**) {#sec3-1-2-5}

Yield: 63% (266 mg, 0.63 mmol), light yellow solid, mp 128--130 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.23 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.75 (dd, 2H, *J* = 8.0, 1.2 Hz), 7.59 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.49--7.38 (m, 4H), 7.22 (dd, 1H, *J* = 8.0, 1.2 Hz), 1.35 (s, 18H); ^13^C NMR (100 MHz, CDCl~3~) δ: 175.9, 150.7, 139.1, 133.6, 133.5, 133.4, 131.3, 130.6, 129.8, 128.4, 127.8, 119.8, 92.9, 88.0, 82.7, 27.6; FT-IR (neat): 2196, 1793, 1753, 1368, 1278, 1251, 1154, 1118, 1097 cm^--1^; HRMS \[ESI\]: calcd for C~25~H~27~NO~5~Na \[M + Na\]^+^ 444.1787; found 444.1771.

#### *N*-Boc-*N*-(4-chlorobenzoyl)-2-(3-phenylprop-2-ynoyl)aniline (**5f**) {#sec3-1-2-6}

Yield: 52% (239 mg, 0.52 mmol), white solid, mp 136--138 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.41 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.75 (d, 2H, *J* = 8.0 Hz), 7.66 (m, 3H), 7.57 (dd, 1H, *J* = 8.0, 8.0 Hz), 7.48 (t, 1H, *J* = 7.2 Hz), 7.41 (m, 4H), 7.32 (d, 1H, *J* = 8.0 Hz), 1.25 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 177.0, 171.2, 152.2, 138.0, 137.3, 135.4, 134.0, 133.7, 133.5, 133.1, 130.9, 130.8, 129.6, 128.7, 128.6, 128.2, 119.9, 93.0, 87.6, 83.9, 27.5; FT-IR (neat): 2197, 1739, 1685, 1644, 1351, 1274, 1248, 1152, 757 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~22~ClNO~4~Na \[M + Na\]^+^ 482.1130; found 482.1117.

#### *N*-Boc-*N*-(4-methoxybenzoyl)-2-(3-phenylprop-2-ynoyl)aniline (**5g**) {#sec3-1-2-7}

Yield: 67% (305 mg, 0.67 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.36 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.80 (d, 2H, *J* = 8.8 Hz), 7.63 (m, 3H), 7.53 (dd, 1H, *J* = 8.0, 8.0 Hz), 7.46 (m, 1H), 7.39 (dd, 2H, *J* = 7.8, 7.8 Hz), 7.30 (d, 1H, *J* = 7.8 Hz), 6.92 (d, 2H, *J* = 8.8 Hz), 3.86 (s, 3H), 1.26 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.9, 171.5, 162.3, 152.6, 138.6, 134.0, 133.9, 133.07, 133.06, 130.8, 130.7, 130.6, 128.9, 128.6, 128.2, 120.0, 113.2, 92.6, 87.7, 83.3, 55.4, 27.5; FT-IR (neat): 2197, 1735, 1679, 1645, 1604, 1350, 1305, 1255, 1174, 1152, 758 cm^--1^; HRMS \[ESI\]: calcd for C~28~H~25~NO~5~Na \[M + Na\]^+^ 478.1625; found 478.1612.

#### *N*-Boc-*N*-(3-chlorobenzoyl)-2-(3-phenylprop-2-ynoyl)aniline (**5h**) {#sec3-1-2-8}

Yield: 65% (299 mg, 0.65 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.42 (dd, 1H, *J* = 7.6, 1.6 Hz), 7.70 (dd, 1H, *J* = 1.6, 1.6 Hz), 7.70 (m, 3H), 7.58 (ddd, 1H, *J* = 7.6, 7.6, 1.2 Hz), 7.39 (m, 7H), 1.23 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.8, 170.8, 152.0, 138.8, 137.9, 134.1, 133.9, 133.7, 133.5, 133.1, 133.0, 130.9, 130.8, 130.7, 129.2, 128.65, 128.63, 128.1, 126.1, 119.9, 92.9, 87.5, 84.0, 27.4; FT-IR (neat): 2980, 2197, 1739, 1686, 1644, 1488, 1352, 1240, 1153, 758 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~22~ClNO~4~Na \[M + Na\]^+^ 482.1130; found 482.1122.

#### *N*-Boc-*N*-(3-methoxybenzoyl)-2-(3-phenylprop-2-ynoyl)aniline (**5i**) {#sec3-1-2-9}

Yield: 71% (323 mg, 0.71 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.39 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.66 (m, 3H), 7.53 (ddd, 1H, *J* = 8.0, 8.0, 1.2 Hz), 7.47 (m, 1H), 7.38 (m, 3H), 7.31 (m, 3H), 6.92 (ddd, 1H, *J* = 8.0, 2.8, 1.2 Hz), 3.84 (s, 3H), 1.23 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.8, 171.9, 1592, 152.3, 138.3, 138.2, 134.0, 133.2, 133.0, 130.7, 130.6, 130.0, 128.9, 128.8, 128.5, 128.4, 128.3, 127.5, 120.4, 119.9, 117.5, 112.9, 92.6, 87.6, 83.5, 55.3, 27.3; FT-IR (neat): 2979, 2196, 1736, 1685, 1644, 1488, 1271, 1154, 757 cm^--1^; HRMS \[ESI\]: calcd for C~28~H~25~NO~5~Na \[M + Na\]^+^ 478.1625; found 478.1618.

#### *N*-Acetyl-*N*-Boc-2-(3-phenylprop-2-ynoyl)aniline (**5j**) {#sec3-1-2-10}

Yield: 61% (222 mg, 0.61 mmol), light yellow solid, mp 85--87 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.31 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.66--7.60 (m, 3H), 7.54--7.46 (m, 2H), 7.41 (m, 2H), 7.17 (dd, 1H, *J* = 8.0, 1.6 Hz), 2.65 (s, 3H), 1.35 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 176.7, 173.6, 152.0, 138.6, 133.9, 133.3, 133.1, 132.8, 130.8, 130.4, 128.7, 128.2, 120.0, 92.6, 87.7, 83.3, 27.7, 26.6; FT-IR (neat): 2196, 1744, 1706, 1642, 1370, 1304, 1279, 1255, 1156 cm^--1^; HRMS \[ESI\]: calcd for C~22~H~21~NO~4~Na \[M + Na\]^+^ 386.1368; found 386.1355.

#### *N*-Boc-*N*-isobutyryl-2-(3-phenylprop-2-ynoyl)aniline (**5k**) {#sec3-1-2-11}

Yield: 48% (188 mg, 0.48 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.34 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.65 (dd, 2H, *J* = 8.8, 1.2 Hz), 7.61 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.53--7.45 (m, 2H), 7.40 (dd, 2H, *J* = 8.8, 8.8 Hz), 7.13 (dd, 1H, *J* = 8.0, 1.6 Hz), 3.85 (sept, 1H, *J* = 6.8 Hz), 1.35 (s, 9H), 1.25 (d, 3H, *J* = 6.8 Hz), 1.24 (d, 3H, *J* = 6.8 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 180.5, 176.6, 151.5, 139.1, 133.7, 133.3, 132.9, 132.8, 130.7, 130.3, 128.5, 127.9, 119.9, 92.3, 87.5, 82.9, 34.6, 27.6, 19.7, 18.9; FT-IR (neat): 2197, 1742, 1701, 1644, 1303, 1275, 1250, 1155, 1074 cm^--1^; HRMS \[ESI\]: calcd for C~24~H~25~NO~4~Na \[M + Na\]^+^ 414.1681; found 414.1667.

#### *N*-Boc-*N*-pivaloyl-2-(3-phenylprop-2-ynoyl)aniline (**5l**) {#sec3-1-2-12}

Yield: 59% (239 mg, 0.59 mmol), light yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.30 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.65 (dd, 2H, *J* = 8.0, 1.6 Hz), 7.58 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.50--7.45 (m, 2H), 7.40 (dd, 2H, *J* = 8.0, 8.0 Hz), 7.10 (dd, 1H, *J* = 8.0, 1.6 Hz), 1.40 (s, 9H), 1.38 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 183.5, 176.8, 152.3, 139.6, 133.9, 133.6, 133.0, 132.9, 130.7, 129.5, 128.6, 127.7, 120.1, 92.3, 87.8, 82.6, 43.4, 27.9, 27.8; FT-IR (neat): 2197, 1733, 1645, 1302, 1276, 1254, 1153, 1072 cm^--1^; HRMS \[ESI\]: calcd forC~25~H~27~NO~4~Na \[M + Na\]^+^ 428.1838; found, 428.1823.

#### *N*,*N*-Di-Boc-2-\[3-(4-chlorophenyl)prop-2-ynoyl\]aniline (**5m**) {#sec3-1-2-13}

Yield: 39% (178 mg, 0.39 mmol), light yellow solid, mp 142--144 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.20 (dd, 1H, *J* = 8.6, 1.6 Hz), 7.73 (m, 2H), 7.60 (ddd, 1H, *J* = 7.6, 7.6, 1.6 Hz), 7.47 (m, 1H), 7.39 (m, 2H), 7.22 (m, 1H), 1.34 (s, 18H); ^13^C NMR (100 MHz, CDCl~3~) δ: 175.5, 150.6, 139.1, 137.0, 134.8, 133.8, 133.3, 131.0, 129.7, 128.8, 127.8, 118.3, 91.6, 88.7, 82.7, 27.6; FT-IR (neat): 2197, 1793, 1368, 1279, 1249, 1153, 1118, 1097 cm^--1^; HRMS \[ESI\]: calcd for C~25~H~27~ClNO~5~ \[M + H\]^+^ 456.1572; found 456.1559.

### General Procedure for the Synthesis of 3-Acyl-4-quinolinone Derivatives 8 {#sec3-1-3}

To a solution of *o*-alkynoylaniline **7** (0.1 mmol, 1.00 equiv) in dry DMF (2 mL, 20.0 mL/mmol) was added 9-AJ (0.03 mmol, 0.300 equiv) at room temperature under argon. After being stirred at 30 °C, the reaction mixture was diluted with water at room temperature. The organic layer was separated, and the aqueous layer was extracted twice with ethyl acetate. The combined organic layers were washed with 1 M aqueous HCl, saturated aqueous NaHCO~3~, and brine; dried over MgSO~4~; and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel to afford 3-acyl-4-quinolinone derivative **8**.

#### 3-Benzoyl-*N*-Boc-2-phenyl-4-quinolinone (**8a**) {#sec3-1-3-1}

Yield: 84% (36 mg, 84 μmol), white solid, mp 144--146 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.45 (dd, 1H, *J* = 8.4, 1.6 Hz), 7.78 (dd, 2H, *J* = 8.0, 1.2 Hz), 7.73 (ddd, 1H, *J* = 8.4, 7.6, 1.6 Hz), 7.63 (d, 1H, *J* = 8.4 Hz), 7.49--7.43 (m, 2H), 7.39 (dd, 2H, *J* = 8.8, 2.0 Hz), 7.34--7.27 (m, 5H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 194.2, 175.6, 149.6, 147.7, 138.0, 137.4, 133.2, 132.9, 132.3, 130.0, 129.4, 129.1, 128.2, 126.8, 126.7, 125.0, 124.8, 123.4, 116.0, 87.3, 26.6; FT-IR (neat): 1763, 1621, 1601, 1471, 1240, 1141, 752 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~23~NO~4~Na \[M + Na\]^+^ 448.1525; found 448.1511.

#### *N*-Boc-3-methoxycarbonyl-2-phenyl-4-quinolinone (**8b**) {#sec3-1-3-2}

Yield: 93% (35 mg, 93 μmol), white solid, mp 136--138 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.47 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.69 (ddd, 1H, *J* = 8.0, 7.6, 1.6 Hz), 7.57 (d, 1H, *J* = 8.0 Hz), 7.53--7.44 (m, 6H), 3.57 (s, 3H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 174.5, 166.0, 149.6, 148.3, 137.8, 133.2, 132.9, 130.3, 129.0, 128.5, 127.0, 125.0, 118.7, 116.0, 87.3, 52.2, 26.7; FT-IR (neat): 1763, 1735, 1629, 1604, 1240, 1142 cm^--1^; HRMS \[ESI\]: calcd for C~22~H~21~NO~5~Na \[M + Na\]^+^ 402.1317; found 402.1302.

#### *N*-Boc-3-ethoxycarbonyl-2-phenyl-4-quinolinone (**8c**) {#sec3-1-3-3}

Yield: 75% (30 mg, 75 μmol), white solid, mp 156--158 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.46 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.68 (ddd, 1H, *J* = 8.0, 6.8, 1.6 Hz), 7.56 (d, 1H, *J* = 8.0 Hz), 7.54--7.43 (m, 6H), 4.04 (q, 2H, *J* = 7.2 Hz), 1.15 (s, 9H), 0.94 (t, 3H, *J* = 7.2 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 174.4, 165.3, 149.5, 148.0, 137.8, 133.2, 132.9, 130.3, 129.1, 128.4, 126.9, 125.0, 124.9, 118.9, 115.9, 87.3, 61.1, 26.6, 13.6; FT-IR (neat): 1764, 1732, 1628, 1604, 1472, 1240, 1142, 1098 cm^--1^; HRMS \[ESI\]: calcd for C~23~H~23~NO~5~Na \[M + Na\]^+^ 416.1474; found 416.1454.

#### *N*-Boc-3-isopropoxycarbonyl-2-phenyl-4-quinolinone (**8d**) {#sec3-1-3-4}

Yield: 44% (18 mg, 44 μmol), white solid, mp 113--115 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.46 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.68 (ddd, 1H, *J* = 8.0, 7.6, 1.6 Hz), 7.56--7.42 (m, 7H), 4.94 (sept, 1H, *J* = 6.4 Hz), 1.14 (s, 9H), 0.96 (d, 6H, *J* = 6.4 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 174.5, 164.8, 149.6, 147.7, 137.8, 133.2, 133.0, 130.3, 129.3, 128.4, 127.0, 125.1, 124.9, 119.3, 115.9, 87.2, 68.8, 26.7, 21.3; FT-IR (neat): 1763, 1728, 1628, 1604, 1472, 1240, 1142, 1095 cm^--1^; HRMS \[ESI\]: calcd for C~24~H~25~NO~5~Na \[M + Na\]^+^ 430.1630; found 430.1612.

#### *N*-Boc-3-(4-chlorobenzoyl)-2-phenyl-4-quinolinone (**8f**) {#sec3-1-3-5}

Yield: 84% (39 mg, 84 μmol), white solid, mp 151--153 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.43 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.72 (m, 3H), 7.62 (d, 1H, *J* = 8.2 Hz), 7.48 (dd, 1H, *J* = 8.0, 8.0 Hz), 7.39--7.28 (m, 7H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 193.1, 175.6, 149.7, 148.1, 139.5, 138.1, 136.0, 133.4, 132.4, 130.6, 130.3, 129.4, 128.7, 128.4, 126.9, 125.1, 122.9, 116.1, 87.5, 26.7; FT-IR (neat): 1764, 1621, 1603, 1471, 1241, 1142, 754 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~22~ClNO~4~Na \[M + Na\]^+^ 482.1130; found 482.1117.

#### *N*-Boc-3-(4-methoxybenzoyl)-2-phenyl-4-quinolinone (**8g**) {#sec3-1-3-6}

Yield: 81% (37 mg, 81 μmol), white solid, mp 160--162 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.45 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.76 (d, 2H, *J* = 8.8 Hz), 7.72 (ddd, 1H, *J* = 8.0, 7.8, 1.6 Hz), 7.63 (d, 1H, *J* = 8.0 Hz), 7.46 (dd, 1H, *J* = 8.0, 7.8 Hz), 7.41 (dd, 2H, *J* = 8.0, 1.6 Hz), 7.36--7.27 (m, 3H), 6.80 (d, 2H, *J* = 8.8 Hz), 3.80 (s, 3H), 1.14 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 192.7, 175.7, 163.5, 149.9, 147.5, 138.1, 133.2, 132.6, 131.7, 130.7, 130.1, 129.4, 128.3, 127.0, 125.0, 124.8, 123.7, 116.0, 113.6, 87.2, 55.4, 26.7; FT-IR (neat): 1763, 1621, 1600, 1471, 1259, 1244, 1156, 1142, 753 cm^--1^; HRMS \[ESI\]: calcd for C~28~H~25~NO~5~Na \[M + Na\]^+^ 478.1625; found 478.1606.

#### *N*-Boc-3-(3-chlorobenzoyl)-2-phenyl-4-quinolinone (**8h**) {#sec3-1-3-7}

Yield: 87% (40 mg, 87 μmol), white solid, mp 149--150 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.44 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.73 (m, 2H), 7.65 (ddd, 1H, *J* = 7.2, 1.6, 1.6 Hz) 7.62 (d, 1H, *J* = 8.8 Hz), 7.49 (ddd, 1H, *J* = 8.0, 8.0, 1.2 Hz), 7.49 (ddd, 1H, *J* = 8.0, 2.2, 1.2 Hz), 7.32 (m, 6H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 193.0, 175.5, 149.5, 148.2, 139.1, 138.0, 134.5, 133.3, 132.8, 132.2, 130.2, 129.6, 129.3, 128.8, 128.3, 127.3, 126.8, 125.0, 122.7, 116.1, 87.5, 26.6; FT-IR (neat): 3009, 1755, 1675, 1598, 1550, 1470, 1235, 1134, 745 cm^--1^; HRMS \[ESI\]: calcd for C~27~H~22~ClNO~4~Na \[M + Na\]^+^ 482.1130; found 482.1121.

#### *N*-Boc-3-(4-methoxybenzoyl)-2-phenyl-4-quinolinone (**8i**) {#sec3-1-3-8}

Yield: 79% (36 mg, 79 μmol), white solid, mp 153--154 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.44 (dd, 1H, *J* = 8.4, 1.2 Hz), 7.72 (ddd, 1H, *J* = 8.6, 7.2, 1.6 Hz), 7.63 (d, 1H, *J* = 8.4 Hz), 7.46 (dd, 1H, *J* = 8.0, 7.8 Hz), 7.47 (ddd, 1H, *J* = 8.0, 6.8, 1.2 Hz), 7.37 (m, 2H), 7.33 (m, 5H), 7.22 (dd, 1H, *J* = 8.0, 8.0 Hz), 6.99 (ddd, 1H, *J* = 8.2, 2.8, 1.2 Hz), 3.77 (s, 3H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 194.1, 175.6, 159.5, 149.7, 147.6, 138.9, 138.1, 133.2, 132.4, 130.1, 129.4, 129.3, 128.3, 126.9, 125.0, 124.8, 123.5, 122.4, 119.7, 116.0, 112.7, 87.3, 55.3, 26.6; FT-IR (neat): 2977, 1753, 1665, 1597, 1469, 1409, 1242, 1138, 994, 750 cm^--1^; HRMS \[ESI\]: calcd for C~28~H~25~NO~5~Na \[M + Na\]^+^ 478.1625; found 478.1614.

#### 3-Acetyl-*N*-Boc-2-phenyl-4-quinolinone (**8j**) {#sec3-1-3-9}

Yield: 25% (9.1 mg, 25 μmol), white solid, mp 145--147 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.45 (dd, 1H, *J* = 8.4, 1.6 Hz), 7.69 (ddd, 1H, *J* = 8.4, 7.6, 1.6 Hz), 7.54--7.44 (m, 7H), 2.33 (s, 3H), 1.15 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 201.1, 175.4, 149.7, 147.5, 137.8, 133.2, 132.7, 130.3, 129.5, 128.5, 126.8, 125.4, 125.3, 125.0, 116.0, 87.4, 32.1, 29.7, 26.7; FT-IR (neat): 1763, 1622, 1602, 1471, 1240, 1142 cm^--1^; HRMS \[ESI\]: calcd for C~22~H~21~NO~4~Na \[M + Na\]^+^ 386.1368; found 386.1355.

#### *N*-Boc-3-isobutyryl-2-phenyl-4-quinolinone (**8k**) {#sec3-1-3-10}

Yield: 35% (14 mg, 35 μmol), white solid, mp 129--131 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.44 (dd, 1H, *J* = 8.4, 1.6 Hz), 7.69 (ddd, 1H, *J* = 8.4, 7.2, 1.6 Hz), 7.56 (d, 1H, *J* = 8.4 Hz), 7.50--7.42 (m, 6H), 2.82 (sept, 1H, *J* = 6.8 Hz), 1.14 (s, 9H), 0.92 (d, 6H, *J* = 6.8 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ: 207.5, 175.6, 149.8, 147.1, 137.9, 133.2, 132.6, 130.2, 129.9, 128.3, 126.8, 125.1, 125.0, 124.9, 116.0, 87.2, 41.4, 26.7, 17.8; FT-IR (neat): 1762, 1623, 1602, 1471, 1240, 1142 cm^--1^; HRMS \[ESI\]: calcd for C~24~H~25~NO~4~Na \[M + Na\]^+^ 414.1681; found 414.1666.

#### *N*-Boc-3-pivaloyl-2-phenyl-4-quinolinone (**8l**) {#sec3-1-3-11}

Yield: 56% (23 mg, 56 μmol), white solid, mp 160--162 °C; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.41 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.69 (ddd, 1H, *J* = 8.0, 7.8, 1.6 Hz), 7.62 (d, 1H, *J* = 8.0 Hz), 7.52--7.42 (m, 6H), 1.13 (s, 9H), 0.88 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 212.5, 175.8, 150.0, 144.6, 138.1, 133.2, 133.0, 130.3, 128.4, 126.61, 126.57, 124.7, 124.6, 116.0, 87.1, 44.5, 26.9, 26.7; FT-IR (neat): 1760, 1621, 1602, 1471, 1240, 1142 cm^--1^; HRMS \[ESI\]: calcd for C~25~H~27~NO~4~Na \[M + Na\]^+^ 428.1838; found 428.1825.

#### (*Z*)-*N*-Boc-2-(phenylmethylen)indolin-3-one (**10**) {#sec3-1-3-12}

Yield: 5% (1.6 mg, 5 μmol), yellow oil; ^1^H NMR (400 MHz, CDCl~3~) δ: 8.15 (s, 1H), 8.03 (d, 1H, *J* = 8.4 Hz), 7.81 (dd, 2H, *J* = 7.2, 1.6 Hz), 7.75 (dd, 1H, *J* = 7.2, 1.6 Hz), 7.60 (ddd, 1H, *J* = 8.0, 7.2, 1.6 Hz), 7.43--7.37 (m, 3H), 7.19 (t, 1H, *J* = 7.4 Hz), 1.70 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 183.0, 150.8, 147.8, 135.7, 133.5, 133.3, 130.6, 129.6, 129.2, 127.8, 124.2, 123.9, 123.6, 117.3, 84.1, 28.3; FT-IR (neat): 1718, 1612, 1477, 1465, 1369, 1325, 1289, 1149, 753 cm^--1^; HRMS \[ESI\]: calcd for C~20~H~19~NO~3~Na \[M + Na\]^+^ 344.1263; found 344.1257.

### Synthesis of 9-AJ Adduct **13m** {#sec3-1-4}

To a solution of *o*-alkynoylaniline derivative **5m** (50.0 mg, 110 μmol, 1.00 equiv) in dry DMF (2.20 mL, 20.0 mL/mmol) was added 9-AJ (21.1 mg, 121 μmol, 1.10 equiv) at room temperature under argon. After being stirred at 30 °C for 10 min, the reaction mixture was quenched with TfOH (9.7 μL, 110 μmol, 1.00 equiv) at 0 °C and concentrated in vacuo. The resulting residue was purified by reverse-phase HPLC (eluted with H~2~O/MeOH = 95/5 to 10/90) to afford 9-AJ adduct (*E*-isomer) **13m** (10 mg, 15.8 μmol, 14%) as a yellow oil.

^1^H NMR (600 MHz, CD~3~OD) δ: 7.98 (dd, 1H, *J* = 7.8, 1.8 Hz), 7.84 (s, 2H), 7.64 (ddd, 1H, *J* = 7.8, 7.8, 1.8 Hz), 7.50 (m, 1H), 7.43 (d, 2H, *J* = 7.8 Hz), 7.35 (d, 2H, *J* = 7.8 Hz), 7.27 (m, 1H), 7.11 (s, 1H), 3.58 (t, 4H, *J* = 6.0 Hz), 2.77 (t, 4H, *J* = 6.0 Hz), 2.01 (m, 4H), 1.32 (s, 18H); ^13^C NMR (150 MHz, CD~3~OD) δ: 191.1, 154.2, 152.9, 151.4, 139.5, 138.5, 137.6, 135.6, 134.8, 133.0, 132.3, 132.0, 131.7, 130.4, 129.6, 124.7, 119.0, 84.4, 51.5, 28.1, 24.8, 20.4; FT-IR (neat): 2939, 2844, 1649, 1596, 1524, 1324, 1273, 1151, 1031, 637 cm^--1^; HRMS \[ESI\]: calcd for C~36~H~41~ClN~3~O~5~ \[M\]^+^ 630.2729; found 630.2715.

^1^H NMR Time Course Experiment of 9-AJ-Catalyzed Reaction Using Substrate **5b** {#sec3-2}
---------------------------------------------------------------------------------

Substrate **5b** (17 mg, 0.05 mmol) was dissolved in DMF-*d*~6~ (1 mL, 20 mL/mmol), and 30 mol % of 9-AJ was added to the mixture at room temperature. The above mixture was kept at 30 °C by immersing in a thermostat bath. The ^1^H NMR spectrum of the resultant solution was measured at the indicated time, as shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}.

Synthesis of *N*-Boc-2-ethynylpyrrole (**19**) {#sec3-3}
----------------------------------------------

To a solution of *N*-Boc-2-bromopyrrole (**18**)^[@ref17]^ (2.07 g, 8.40 mmol, 1.00 equiv) in dry 1,4-dioxane (16.8 mL, 2.00 mL/mmol) were added TMS acetylene (1.54 mL, 10.9 mmol, 1.30 equiv), triethylamine (3.51 mL, 25.1 mmol, 3.00 equiv), Pd(PPh~3~)~4~ (96.0 mg, 84.0 μmol, 0.0100 equiv), and CuI (27.9 mg, 147 μmol, 0.0200 equiv) under argon. After being stirred at 80 °C for 24 h in a sealed tube, the reaction mixture was diluted with water. The organic layer was separated, and the aqueous layer was extracted with diethyl ether. The combined organic layers were washed with saturated aqueous NH~4~Cl and brine, dried over MgSO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was passed through a short pad of silica gel to afford the TMS acetylene derivative. The product afforded was used for the next reaction without further purification.

To a solution of the crude TMS acetylene derivative in dry THF (25.2 mL, 3.00 mL/mmol) was added tetrabutylammonium fluoride (TBAF, 1.00 M in THF solution, 10.1 mL, 1.20 equiv) dropwise at 0 °C under argon. After being stirred at room temperature for 1.5 h, the reaction mixture was quenched with 1 M aqueous HCl at 0 °C. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NaHCO~3~ and brine, dried over MgSO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel (eluted with hexane/ethyl acetate = 100/1) to afford 2-ethynylpyrrole **19** (1.42 g, 7.42 mmol, 88%) as a light yellow oil.

^1^H NMR (400 MHz, CDCl~3~) δ: 7.26 (m, 1H), 6.61 (dd, 1H, *J* = 3.4, 2.0 Hz), 6.14 (dd, 1H, *J* = 3.4, 3.4 Hz), 3.36 (s, 1H), 1.62 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 148.2, 122.6, 121.9, 114.2, 110.8, 84.7, 81.2, 75.8, 27.8; FT-IR (neat): 3290, 2982, 1745, 1338, 1316, 1125 cm^--1^; HRMS \[EI\]: calcd for C~11~H~13~NO~2~ 191.0946; found 191.0942.

### *N*-Boc-*N*-methoxycarbonyl 2-\[3-(*N*-Boc-2-pyrrolyl)prop-2-ynoyl\]aniline (**4**) {#sec3-3-1}

In a 50 mL autoclave containing a glass tube were placed *N*-Boc-*N*-methoxycarbonyl-2-iodoaniline (**7b**) (977 mg, 2.59 mmol, 1.00 equiv), 2-ethynylpyrrole **19** (595 mg, 3.11 mmol, 1.20 equiv), triethylamine (1.08 mL, 7.77 mmol, 3.00 equiv), DMF (15.5 mL, 6.00 mL/mmol), Pd(PPh~3~)~4~ (29.9 mg, 25.9 μmol, 0.0100 equiv), and CuI (9.9 mg, 51.8 μmol, 0.0200 equiv). The autoclave was filled with carbon monoxide (50 atm) after being purged with carbon monoxide three times. The reaction was carried out under an appropriate carbon monoxide pressure at 80 °C for 12 h. The reaction mixture was diluted with water. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NH~4~Cl and brine, dried over MgSO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel (eluted with hexane/ethyl acetate = 15/1 to 7/1) to afford *o*-alkynoylaniline derivative **4** (776 mg, 1.66 mmol, 64%) as a yellow oil.

^1^H NMR (400 MHz, CDCl~3~) δ: 8.46 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.60 (ddd, 1H, *J* = 8.0, 7.6, 1.6 Hz), 7.51 (ddd, 1H, *J* = 8.0, 8.0, 1.2 Hz), 7.44 (m, 1H), 7.21 (d, 1H, *J* = 7.6 Hz), 7.02 (m, 1H), 6.27 (dd, 1H, *J* = 3.2, 3.2 Hz), 3.72 (s, 3H), 1.65 (s, 9H), 1.36 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ: 175.6, 152.8, 150.3, 147.5, 137.9, 133.4, 133.1, 132.7, 129.8, 128.1, 126.5, 125.6, 112.2, 111.7, 92.8, 85.7, 85.3, 82.8, 53.4, 27.7, 27.5; FT-IR (neat): 2183, 1797, 1752, 1636, 1370, 1317, 1275, 1251, 1223, 1159, 1136, 1102 cm^--1^; HRMS \[ESI\]: calcd for C~25~H~28~N~2~O~7~Na \[M + Na\]^+^ 491.1794; found 491.1776.

### Methyl Penicinoline (**3**) {#sec3-3-2}

To a solution of *o*-alkynoylaniline derivative **4** (100 mg, 213 μmol, 1.00 equiv) in dry DMF (4.26 mL, 20.0 mL/mmol) was added 9-AJ (11.0 mg, 63.9 μmol, 0.300 equiv) at room temperature under argon. After being stirred at 80 °C for 36 h, the reaction mixture was diluted with water at room temperature. The organic layer was separated, and the aqueous layer was extracted twice with ethyl acetate. The combined organic layers were washed with brine, dried over Na~2~SO~4~, and filtered. The filtrate was concentrated in vacuo. The crude product was used for the next reaction without further purification.

To a solution of the crude product in dry CH~2~Cl~2~ (10.5 mL, 50.0 mL/mmol) was added trifluoroacetic acid (1.05 mL, 5.00 mL/mmol) dropwise at 0 °C under argon. After being stirred at the same temperature, the reaction mixture was quenched with saturated aqueous NaHCO~3~ at 0 °C. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over Na~2~SO~4~, and filtered. The filtrate was concentrated in vacuo, and then the resulting residue was purified by column chromatography on silica gel (eluted with hexane/ethyl acetate = 1/1 to ethyl acetate) to afford methyl penicinoline (**3**) (31.0 mg, 116 μmol, 54%) as a light brown solid.

mp \> 300 °C (lit.^[@ref17]^ \> 300 °C); ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 11.7 (m, 2H), 8.05 (d, 1H, *J* = 8.4 Hz), 7.68 (m, 2H), 7.34 (m, 1H), 7.12 (m, 1H), 6.45 (d, 1H, *J* = 3.4 Hz), 6.24 (dd, 1H, *J* = 3.4, 2.4 Hz), 3.66 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 173.5, 167.7, 140.7, 139.6, 132.3, 124.8, 124.2, 123.6, 123.0, 122.5, 118.6, 113.5, 111.9, 109.8 51.9; FT-IR (neat): 3200, 2923, 1724, 1588, 1558, 1456, 1354, 1135 cm^--1^; HRMS \[ESI\]: calcd for C~15~H~12~N~2~O~3~Na \[M + Na\]^+^ 291.0746; found 291.0736.

### Quinolactacide (**1**) {#sec3-3-3}

To a solution of methyl penicinoline (**3**) (7.5 mg, 28.0 μmol, 1.00 equiv) in dry THF (2.80 mL, 100 mL/mmol) was added DBU (12.6 μL, 84.0 μmol, 3.00 equiv) at room temperature under argon. The reaction mixture was heated under reflux for 9 h. After cooling to room temperature, the reaction mixture was concentrated in vacuo. The resulting residue was purified by column chromatography on silica gel (eluted with chloroform/methanol = 20/1 to 10/1) to afford quinolactacide (**1**) (6.0 mg, 25.4 μmol, 91%) as a yellow solid.

mp \> 300 °C (lit.^[@ref2]^ 373--374 °C, decomposition); ^1^H NMR (600 MHz, DMSO-*d*~6~) δ: 13.2 (br s, 1H), 8.12 (dd, 1H, *J* = 8.4, 1.8 Hz), 7.70 (ddd, 1H, *J* = 8.4, 8.4, 1.8 Hz), 7.57 (d, 1H, *J* = 8.4 Hz), 7.41 (m, 2H), 6.72 (d, 1H, *J* = 3.6 Hz), 6.36 (dd, 1H, *J* = 3.6, 3.6 Hz); ^13^C NMR (150 MHz, DMSO-*d*~6~) δ: 170.6, 160.1, 151.6, 139.3, 132.6, 127.8, 126.2, 125.7, 125.3, 119.6, 119.5, 116.4, 112.7, 104.0; FT-IR (neat): 3304, 2921, 1743, 1645, 1583, 1538, 1473 cm^--1^; HRMS \[ESI\]: calcd for C~14~H~8~N~2~O~2~Na \[M + Na\]^+^ 259.0483; found 259.0475.

### Penicinotam (**20**) {#sec3-3-4}

To a solution of quinolactacide (**1**) (4.0 mg, 16.8 μmol, 1.00 equiv) in dry acetone (4.00 mL) were added potassium carbonate (23.0 mg, 168 μmol, 10.0 equiv) and iodomethane (11.0 μL, 168 μmol, 10.0 equiv) at 0 °C under argon. After being stirred at room temperature for 14 h, the reaction mixture was filtered through a pad of Celite, and the filtrate was concentrated in vacuo. The resulting residue was purified by column chromatography on silica gel (eluted with chloroform/methanol = 100/1) to afford penicinotam (**20**) (4.0 mg, 16.0 μmol, 95%) as a yellow solid.

mp \> 300 °C (lit.^[@cit3a]^ 323--325 °C); ^1^H NMR (600 MHz, DMSO-*d*~6~) δ: 8.22 (dd, 1H, *J* = 8.0, 1.6 Hz), 7.92 (d, 1H, *J* = 8.0 Hz), 7.80 (ddd, 1H, *J* = 8.0, 8.0, 1.6 Hz), 7.52--7.49 (m, 2H), 7.11 (dd, 1H, *J* = 3.2, 0.6 Hz), 6.44 (dd, 1H, *J* = 3.2, 3.2 Hz), 4.00 (s, 3H); ^13^C NMR (150 MHz, DMSO-*d*~6~) δ: 170.0, 159.6, 153.8, 140.4, 132.8, 128.7, 126.0, 125.63, 125.58, 120.2, 117.8, 116.7, 116.6, 104.3, 36.7; FT-IR (neat): 2922, 2851, 1742, 1607, 1568, 1498, 1260, 734 cm^--1^; HRMS \[ESI\]: calcd for C~15~H~10~N~2~O~2~Na \[M + Na\]^+^ 273.0640; found 273.0631.
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